(Total Views: 483)
Posted On: 06/25/2019 10:05:40 AM
Post# of 103535
$RFL News Article - Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613 (devimistat) in Japan and Other Asian Countries https://marketwirenews.com/news-releases/rafa...09954.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
